vm202
Gene therapyexperimental
Clinical trial activity
17 trials · 10 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
15
Phase 3
4
Phase 4
0
Earliest trial started Jan 1, 2007 (NCT01422772)
Timeline
Indications
Studied for
- Amyotrophic Lateral Sclerosis · Phase 2
- Charcot-Marie-Tooth Disease · Phase 1/Phase 2
- Chronic Limb-Threatening Ischemia · Phase 2
- Diabetes Mellitus · Phase 3
- Diabetic Foot · Phase 3
- Diabetic Neuropathies · Phase 3
- Myocardial Infarction · Phase 2
- Myocardial Ischemia · Phase 2
- Pain · Phase 1/Phase 2
- Peripheral Arterial Disease · Phase 2
Mechanism of action
- Hepatocyte growth factorSupplementation
HGF supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vm202
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05176093 | Phase 2 | Nov 14, 2021 | Helixmith Co., Ltd. |
| NCT04873232 | Phase 3 | May 17, 2021 | Helixmith Co., Ltd. |
| NCT04632225 | Phase 2 | Dec 1, 2020 | Helixmith Co., Ltd. |
| NCT04469270 | Phase 3 | Oct 9, 2020 | Helixmith Co., Ltd. |
| NCT05361031 | Phase 1/Phase 2 (Phase 2) | Sep 21, 2020 | Helixmith Co., Ltd. |
| NCT04087941 | Phase 2 | Nov 30, 2019 | Harvard University |
| NCT03404024 | Phase 2 | Jan 25, 2018 | Ewha Womans University, ViroMed |
| NCT03363165 | Phase 2 | Jan 1, 2018 | National Institute on Aging (NIA), Northwestern University, ViroMed |
| NCT02563522 | Phase 3 | Dec 1, 2016 | Texas Heart Institute, ViroMed |
| NCT02427464 | Phase 3 | Apr 1, 2016 | Navigant, Northwestern University, ViroMed |
| NCT01002495 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2015 | ViroMed |
| NCT02039401 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2014 | Northwestern University, ViroMed |
| NCT01475786 | Phase 2 | Aug 1, 2012 | Northwestern University, ViroMed |
| NCT01064440 | Phase 2 | Mar 1, 2010 | Texas Heart Institute, ViroMed |
| NCT01002235 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2010 | Northwestern University, ViroMed |
| NCT00696124 | Phase 1 | Mar 1, 2007 | Minneapolis Heart Institute, ViroMed |
| NCT01422772 | Phase 1 | Jan 1, 2007 | Seoul National University, ViroMed |
Showing 17 of 17 trials
Page 1 / 1
Organizations
Research & Development (10)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ViroMed | For profit | 11 | 10 | 3 | 2007 |
| Helixmith Co., Ltd. | For profit | 5 | 5 | 2 | 2020 |
| Northwestern University | Academic/Hospital | 5 | 1 | 2 | 2010 |
| Texas Heart Institute | Academic/Hospital | 2 | 0 | 2 | 2010 |
| Ewha Womans University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Minneapolis Heart Institute | Academic/Hospital | 1 | 0 | 1 | 2007 |
| National Institute on Aging (NIA) | Government | 1 | 0 | 1 | 2018 |
| Navigant | For profit | 1 | 0 | 1 | 2016 |
| Seoul National University | Academic/Hospital | 1 | 0 | 1 | 2007 |
10 organizations
Page 1 / 1